Rapid Communication
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. May 21, 2007; 13(19): 2733-2737
Published online May 21, 2007. doi: 10.3748/wjg.v13.i19.2733
Table 2 Clinical course of patients in the study and control groups
Study groupControl groupP
Median duration of hospital stay ± (range)10 ± 4 (8-14)15 ± 6 (7-26)< 0.05
Median value of days in ICU ± (range)6 ± 2 (5-8)6 ± 2 (5-7)NS
Median duration of EN ± (range)8 ± 4 (6-12)10 ± 4 (6-13)NS
Median duration (days) of serum amylase or lipase normalization ± (range)7 ± 2 (6-9)8 ± 3 (6-11)NS
Complications
Multiorgan failure (n)12
Cholangitis (n)10
Sepsis (n)12
Pseudocyst (n)21
Number of deaths (n)24
Overall complications (%)7/15 (46.6)9/15 (60%)< 0.05